Beta Bionics CCO sells 370 shares
Beta Bionics Chief Commercial Officer Mark Hopman sold 370 shares of common stock on Oct. 1, 2026. Shares sold at a weighted average price of $18.96, within a $18.96 to $19.9599 range. Holdings fell to 56,109 shares following the transaction.